HgCapital Trust (LON:HGT) Sets New 1-Year High – Time to Buy?
by Sarita Garza · The Markets DailyHgCapital Trust plc (LON:HGT – Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as GBX 550 ($6.91) and last traded at GBX 544 ($6.84), with a volume of 413181 shares trading hands. The stock had previously closed at GBX 537 ($6.75).
HgCapital Trust Price Performance
The business has a 50-day moving average price of GBX 515.61 and a 200 day moving average price of GBX 506.52. The stock has a market cap of £2.44 billion, a PE ratio of 1,078.00 and a beta of 0.44. The company has a current ratio of 131.50, a quick ratio of 274.70 and a debt-to-equity ratio of 6.58.
HgCapital Trust Cuts Dividend
The firm also recently announced a dividend, which was paid on Friday, October 25th. Shareholders of record on Thursday, September 26th were given a dividend of GBX 2 ($0.03) per share. The ex-dividend date was Thursday, September 26th. This represents a yield of 0.39%. HgCapital Trust’s dividend payout ratio is presently 1,400.00%.
Insider Activity
In related news, insider Richard J. Brooman bought 4,000 shares of the business’s stock in a transaction on Tuesday, September 24th. The stock was acquired at an average price of GBX 498 ($6.26) per share, for a total transaction of £19,920 ($25,040.85). Insiders own 8.44% of the company’s stock.
About HgCapital Trust
Hg Capital Trust plc specializes in direct, quoted and unquoted companies and fund of funds investments. The funds maximum exposure to unlisted investments is 100% of the gross assets and single investment in an unlisted company or closed-ended investments fund, whether made directly or indirectly, will exceed a maximum of 15% of gross assets.
Further Reading
- Five stocks we like better than HgCapital Trust
- Differences Between Momentum Investing and Long Term Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Use the MarketBeat Stock Screener
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 2 Generic Drug Stocks Ready to Surge in 2025